Why is Lotus Eye Hospit falling/rising?

As of 14-Jul, Lotus Eye Hospital & Institute Ltd is experiencing a price increase, currently at 73.60, reflecting a change of 0.79 or 1.09% upward. The stock has shown varied performance over different periods, with a 1-month return of +2.22% compared to the Sensex's +1.40%, and a year-to-date return of +6.93% against the Sensex's +5.27%. However, it has underperformed in the short term with a 1-week decline of -2.05%. Today's price summary indicates that the stock has outperformed its sector by 0.32%, although there is a notable decline in investor participation, with delivery volume falling by 70.61% against the 5-day average. The company maintains a low debt-to-equity ratio, which is a positive factor, but the majority of shareholders are non-institutional, which could influence stability.
In the broader market context, the stock's recent performance contrasts with the benchmark, as it has outperformed the Sensex over the past month but has seen a decline over the past week while the Sensex also fell by -1.42%. The stock's liquidity remains adequate for trading, suggesting that while there are some positive indicators, the significant drop in delivery volume may raise concerns among investors. Overall, the combination of solid long-term returns and current price movement reflects a mixed sentiment in the market, influenced by both internal company factors and broader market trends.